Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1450-1466.e11
Open Access | Times Cited: 18

Showing 18 citing articles:

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Advancing Natural Killer Cell Therapy: Genetic Engineering Strategies for Enhanced Cancer Immunotherapy
Joo Dong Park, Ha Eun Shin, Y. An, et al.
Annals of Laboratory Medicine (2025)
Open Access | Times Cited: 2
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Head-to-head: IL-21 triumphs over IL-15 in NK cell therapy for glioblastoma
JulieAnn Miller, Bihui Cao, Jia Shen
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy
Indrani Nayak, Rosalba Biondo, William C. Stewart, et al.
Immunology and Cell Biology (2025)
Open Access
Targeting γc family cytokines with biologics: current status and future prospects
Fabian Bick, Christophe Blanchetot, Bart N. Lambrecht, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Agent-based modeling of cellular dynamics in adoptive cell therapy
Yujia Wang, Stefano Casarin, May Daher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Highlights of 2024: Cytokines and ligands modulating NK cell effector functions
Aneena Mary Shajan, Louisa Alim, Fernando Souza‐Fonseca‐Guimaraes
Immunology and Cell Biology (2025)
Closed Access
Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells
Brian Meehan, Lata Adnani, Xianbing Zhu, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Attenuated Salmonella carrying IL-21 overexpression plasmid enhances radiotherapy efficacy in a preclinical model of melanoma
Wei Tian, Mengyu Lei, Hanyu Jiang, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114590-114590
Closed Access
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
Bailin He, Hong Chen, Jiaxu Wu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
Cytokine-mediated regulation of immune cell metabolic pathways in the tumor microenvironment
Alireza Soleimani Mamalo, Mohammad Reza Pashaei, Mohammad Valilo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Transcriptomics of Various Diseases Reveals the Core Role of Immune System Pathways in Retinal Damage Repair and Nerve Regeneration
Yuxiang Zhang, Jianlin Pan, Dongqiang Zeng, et al.
Molecular Neurobiology (2025)
Closed Access
Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesis
Bo Tan, Tao Chen, Peng Song, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Cytokines in Focus: IL-2 and IL-15 in NK Adoptive Cell Cancer Immunotherapy
Bryan Marr, Donghyeon Jo, Mihue Jang, et al.
Immune Network (2025) Vol. 25, Iss. 2
Open Access
When playing the NK cell therapy card in glioblastoma, you can’t beat interleukin-21
Nicholas D. Huntington
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1333-1335
Closed Access
Advances and challenges in chimeric antigen receptor‐natural killer cell immunotherapy for cancer
Hind Rafei, Katayoun Rezvani
British Journal of Haematology (2024)
Open Access
γc-Family Cytokines in Health and Disease
Warren J. Leonard, Hrishikesh Pandit, Rosanne Spolski, et al.
Elsevier eBooks (2024)
Closed Access
Page 1

Scroll to top